Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0UD1U
|
||||
| Former ID |
DNC014354
|
||||
| Drug Name |
Erysubin D
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C25H28O5
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=C2C(=C1)C3C(CO2)C4=C(O3)C5=C(C=C4)OC(C(C5)<br />O)(C)C)O)C
|
||||
| InChI |
1S/C25H28O5/c1-13(2)5-6-14-9-16-21(11-19(14)26)28-12-18-15-7-8-20-17(23(15)29-24(16)18)10-22(27)25(3,4)30-20/h5,7-9,11,18,22,24,26-27H,6,10,12H2,1-4H3/t18-,22?,24-/m0/s1
|
||||
| InChIKey |
UNODSKHATHZQGW-HRKCMRQESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||